These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 29205751)

  • 1. LH-21 and abnormal cannabidiol improve β-cell function in isolated human and mouse islets through GPR55-dependent and -independent signalling.
    Ruz-Maldonado I; Pingitore A; Liu B; Atanes P; Huang GC; Baker D; Alonso FJ; Bermúdez-Silva FJ; Persaud SJ
    Diabetes Obes Metab; 2018 Apr; 20(4):930-942. PubMed ID: 29205751
    [TBL] [Abstract][Full Text] [Related]  

  • 2. GPR55-dependent stimulation of insulin secretion from isolated mouse and human islets of Langerhans.
    Liu B; Song S; Ruz-Maldonado I; Pingitore A; Huang GC; Baker D; Jones PM; Persaud SJ
    Diabetes Obes Metab; 2016 Dec; 18(12):1263-1273. PubMed ID: 27561953
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of the insulin releasing and antihyperglycaemic activities of GPR55 lipid agonists using clonal beta-cells, isolated pancreatic islets and mice.
    McKillop AM; Moran BM; Abdel-Wahab YH; Flatt PR
    Br J Pharmacol; 2013 Nov; 170(5):978-90. PubMed ID: 23992544
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The cannabinoid ligands SR141716A and AM251 enhance human and mouse islet function via GPR55-independent signalling.
    Ruz-Maldonado I; Liu B; Atanes P; Pingitore A; Huang GC; Choudhary P; Persaud SJ
    Cell Mol Life Sci; 2020 Nov; 77(22):4709-4723. PubMed ID: 31925452
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Direct Stimulatory Effects of the CB
    Ruz-Maldonado I; Atanes P; Huang GC; Liu B; Persaud SJ
    Cells; 2021 Mar; 10(3):. PubMed ID: 33809893
    [TBL] [Abstract][Full Text] [Related]  

  • 6. G-protein coupled receptor 55 agonists increase insulin secretion through inositol trisphosphate-mediated calcium release in pancreatic β-cells.
    Vong CT; Tseng HHL; Kwan YW; Lee SM; Hoi MPM
    Eur J Pharmacol; 2019 Jul; 854():372-379. PubMed ID: 31054273
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Metabolic effects of orally administered small-molecule agonists of GPR55 and GPR119 in multiple low-dose streptozotocin-induced diabetic and incretin-receptor-knockout mice.
    McKillop AM; Moran BM; Abdel-Wahab YH; Gormley NM; Flatt PR
    Diabetologia; 2016 Dec; 59(12):2674-2685. PubMed ID: 27677765
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A role for the putative cannabinoid receptor GPR55 in the islets of Langerhans.
    Romero-Zerbo SY; Rafacho A; Díaz-Arteaga A; Suárez J; Quesada I; Imbernon M; Ross RA; Dieguez C; Rodríguez de Fonseca F; Nogueiras R; Nadal A; Bermúdez-Silva FJ
    J Endocrinol; 2011 Nov; 211(2):177-85. PubMed ID: 21885477
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CRISPR/Cas9 gene editing demonstrates metabolic importance of GPR55 in the modulation of GIP release and pancreatic beta cell function.
    McCloskey AG; Miskelly MG; Moore CBT; Nesbit MA; Christie KA; Owolabi AI; Flatt PR; McKillop AM
    Peptides; 2020 Mar; 125():170251. PubMed ID: 31923454
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Novel protective effect of O-1602 and abnormal cannabidiol, GPR55 agonists, on ER stress-induced apoptosis in pancreatic β-cells.
    Vong CT; Tseng HHL; Kwan YW; Lee SM; Hoi MPM
    Biomed Pharmacother; 2019 Mar; 111():1176-1186. PubMed ID: 30841431
    [TBL] [Abstract][Full Text] [Related]  

  • 11. N-arachidonoyl glycine, an abundant endogenous lipid, potently drives directed cellular migration through GPR18, the putative abnormal cannabidiol receptor.
    McHugh D; Hu SS; Rimmerman N; Juknat A; Vogel Z; Walker JM; Bradshaw HB
    BMC Neurosci; 2010 Mar; 11():44. PubMed ID: 20346144
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A GPR18-based signalling system regulates IOP in murine eye.
    Caldwell MD; Hu SS; Viswanathan S; Bradshaw H; Kelly ME; Straiker A
    Br J Pharmacol; 2013 Jun; 169(4):834-43. PubMed ID: 23461720
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Abnormal cannabidiol ameliorates inflammation preserving pancreatic beta cells in mouse models of experimental type 1 diabetes and beta cell damage.
    González-Mariscal I; Pozo-Morales M; Romero-Zerbo SY; Espinosa-Jimenez V; Escamilla-Sánchez A; Sánchez-Salido L; Cobo-Vuilleumier N; Gauthier BR; Bermúdez-Silva FJ
    Biomed Pharmacother; 2022 Jan; 145():112361. PubMed ID: 34872800
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Short chain fatty acids stimulate insulin secretion and reduce apoptosis in mouse and human islets in vitro: Role of free fatty acid receptor 2.
    Pingitore A; Gonzalez-Abuin N; Ruz-Maldonado I; Huang GC; Frost G; Persaud SJ
    Diabetes Obes Metab; 2019 Feb; 21(2):330-339. PubMed ID: 30203438
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antidiabetic actions of GPR55 agonist Abn-CBD and sitagliptin in obese-diabetic high fat fed mice.
    McCloskey AG; Miskelly MG; Lafferty RA; Flatt PR; McKillop AM
    Biochem Pharmacol; 2023 Feb; 208():115398. PubMed ID: 36581052
    [TBL] [Abstract][Full Text] [Related]  

  • 16. GPR55: A therapeutic target for Parkinson's disease?
    Celorrio M; Rojo-Bustamante E; Fernández-Suárez D; Sáez E; Estella-Hermoso de Mendoza A; Müller CE; Ramírez MJ; Oyarzábal J; Franco R; Aymerich MS
    Neuropharmacology; 2017 Oct; 125():319-332. PubMed ID: 28807673
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Global deletion of G protein-coupled receptor 55 impairs glucose homeostasis during obesity by reducing insulin secretion and β-cell turnover.
    Liu B; Ruz-Maldonado I; Persaud SJ
    Diabetes Obes Metab; 2024 Oct; 26(10):4591-4601. PubMed ID: 39113250
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nonpsychotropic cannabinoids, abnormal cannabidiol and canabigerol-dimethyl heptyl, act at novel cannabinoid receptors to reduce intraocular pressure.
    Szczesniak AM; Maor Y; Robertson H; Hung O; Kelly ME
    J Ocul Pharmacol Ther; 2011 Oct; 27(5):427-35. PubMed ID: 21770780
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Involvement of a non-CB1/CB2 cannabinoid receptor in the aqueous humor outflow-enhancing effects of abnormal-cannabidiol.
    Qiao Z; Kumar A; Kumar P; Song ZH
    Exp Eye Res; 2012 Jul; 100():59-64. PubMed ID: 22580290
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Atypical Cannabinoid Abn-CBD Reduces Inflammation and Protects Liver, Pancreas, and Adipose Tissue in a Mouse Model of Prediabetes and Non-alcoholic Fatty Liver Disease.
    Romero-Zerbo SY; García-Fernández M; Espinosa-Jiménez V; Pozo-Morales M; Escamilla-Sánchez A; Sánchez-Salido L; Lara E; Cobo-Vuilleumier N; Rafacho A; Olveira G; Rojo-Martínez G; Gauthier BR; González-Mariscal I; Bermúdez-Silva FJ
    Front Endocrinol (Lausanne); 2020; 11():103. PubMed ID: 32210914
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.